Oxidative modifications of cerebral transthyretin are associated with multiple sclerosis

Proteomics

Volumn 13, Issue 6, 2013, Pages 1002-1009

  Pieragostino, Damiana ^a   Del Boccio, Piero ^a   Di Ioia, Maria ^a   Pieroni, Luisa ^b,c   Greco, Viviana ^b,c   De Luca, Giovanna ^a   D'Aguanno, Simona ^b,c   Rossi, Claudia ^a   Franciotta, Diego ^d   Centonze, Diego ^b   Sacchetta, Paolo ^a   Di Ilio, Carmine ^a   Lugaresi, Alessandra ^a   Urbani, Andrea ^b,c  

^a UNIVERSITY OF CHIETI   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

Author keywords

Biomedicine; CSF transthyretin; Multiple sclerosis; PTMs

Indexed keywords

PREALBUMIN; THYROXINE;

ADULT; ARTICLE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HORMONE TRANSPORT; HUMAN; HYDRATION; MALE; MULTIPLE SCLEROSIS; OXIDATION; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN FOLDING; PROTEIN PROCESSING; SULFONATION;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OXIDATION-REDUCTION; PREALBUMIN; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; THYROXINE;

EID: 84874972336     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201200395     Document Type: Article

References (36)

1. Sospedra, M., Martin, R., Immunology of multiple sclerosis. Annu. Rev. Immunol. 2005, 23, 683-747.
2. D'Intino, G., Perretta, G., Taglioni, A., Calistri, M. et al., Endogenous stem and precursor cells for demyelinating diseases: an alternative for transplantation? Neurol. Res. 2006, 28, 513-517.
3. Calzà, L., Fernandez, M., Giardino, L., Cellular approaches to central nervous system remyelination stimulation: thyroid hormone to promote myelin repair via endogenous stem and precursor cells. J. Mol. Endocrinol. 2010, 44, 13-23.
4. Dell'acqua, M. L., Lorenzini, L., D'Intino, G., Functional and molecular evidence of myelin- and neuro-protection by thyroid hormone administration in experimental allergic encephalomyelitis. Neuropathol. Appl. Neurobiol. 2012, 38, 454-470.
5. Chanoine, J. P., Alex, S., Fang, S. L., Stone, S. et al., Role of transthyretin in the transport of thyroxine from the blood to the choroid plexus, the cerebrospinal fluid, and the brain. Endocrinology 1992, 130, 933-938.
6. Palha, J. A., Nissanov, J., Fernandes, R., Sousa, J.C. et al., Thyroid hormone distribution in the mouse brain: the role of transthyretin. Neuroscience 2002, 113, 837-847.
7. Sinha, A. K., Pickard, M. R., Kim, K. D., Ahmed, M. T. et al., Perturbation of thyroid hormone homeostasis in the adult and brain function. Acta Med. Austriaca 1994, 21, 35-43.
8. Wojtczak, A., Cody, V., Luft, J. R., Pangborn, W., Structure of human transthyretin complexed with thyroxine at 2.0 Å resolution and 3′, 5′-dinitro-N-acetyl-L-thyronine at 2.2 Å resolution. Acta Crystallogr. 1996, 52, 758-765.
9. Kawahara, S., Ueda, M., Miyazaki, A., Yuki, U. et al., Age-dependent increase in thiol conjugated forms of transthyretin (TTR) in the elderly: quantitative analyses by the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) protein chip system. Amyloid 2011, 18(Suppl 1), 9-11.
10. Kelly, J. W., Colon, W., Lai, Z., Lashuel, H. A. et al., Transthyretin quaternary and tertiary structural changes facilitate misassembly into amyloid. Adv. Protein. Chem. 1997, 50, 161-181.
11. Connelly, S., Choi, S., Johnson, S.M., Kelly, J. W. et al., Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses. Curr. Opin. Struct. Biol. 2010, 20, 54-62.
12. Du, J., Murphy, R. M., Characterization of the interaction of β-amyloid with transthyretin monomers and tetramers. Biochemistry 2010, 49, 8276-8289.
13. Hou, X., Aguilar, M. I., Small, D. H., Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration. FEBS J. 2007, 274, 1637-1650.
14. McDonald, W. I., Compston, A., Edan, G., Goodkin, D. et al., Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann. Neurol. 2001, 50, 121-127.
15. Frohman, E. M., Goodin, D. S., Calabresi, P. A., Corboy, J. R. et al., The utility of MRI in suspected MS: report of the therapeutics and technology assessment subcommittee of the american academy of neurology. Neurology 2003, 61, 602-611.
16. Kurtzke, J. F., Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983, 33, 1444-1452.
17. Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M. et al., Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 2011, 69, 292-302.
18. Ellsworth, C., Alvord, J. R., in: Vinken, P. J., Bruyn, G. W. (Eds.), Handbook of Clinical Neurology, Demyelinating Disease, Elsevier, Amsterdam 1985, pp. 467-502.
19. Del Boccio, P., Pieragostino, D., Lugaresi, A., Di Ioia, M. et al., Cleavage of cystatin C is not associated with multiple sclerosis, Ann. Neurol. 2007, 62, 201-204.
20. Biroccio, A., Del Boccio, P., Panella, M., Bernardini, S., et al., Differential post-translational modifications of transthyretin in Alzheimer's disease: a study of the cerebral spinal fluid. Proteomics 2006, 6, 2305-2313.
21. Pieragostino, D., Petrucci, F., Del Boccio, P., Mantini, D. et al., Pre-analytical factors in clinical proteomics investigations: impact of ex vivo protein modifications for multiple sclerosis biomarker discovery. J. Proteomics 2010, 73, 579-592.
22. Towbin, H., Staehelin, T., Gordon, J., Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Biotechnology 1992, 24, 145-149.
23. Mantini, D., Petrucci, F., Pieragostino, D., Del Boccio, P. et al., LIMPIC: a computational method for the separation of protein MALDI-TOF-MS signals from noise. BMC Bioinformatics 2007, 8, 101.
24. Mantini D, Petrucci F, Pieragostino D, Del Boccio, P. et al., A computational platform for MALDI-TOF mass spectrometry data: application to serum and plasma samples. J. Proteomics 2010, 73, 562-570.
25. Nakanishi, T., Sato, T., Sakoda, S., Yoshioka, M. et al., Modification of cysteine residue in transthyretin and a synthetic peptide: analyses by electrospray ionization mass spectrometry. Biochim. Biophys. Acta 2004, 1698, 45-53.
26. Kishikawa, M., Nakanishi, T., Miyazaki, A., Shimizu, A. et al., Simple detection of abnormal serum transthyretin from patients with familial amyloidotic polyneuropathy by highperformance liquid chromatography/electrospray ionization mass spectrometry using material precipitated with specific antiserum. J. Mass Spectrom. 1996, 31, 112-114.
27. Kishikawa, M., Nakanishi, T., Miyazaki, A., Shimizu, A., A simple and reliable method of detecting variant transthyretins by multidimensional liquid chromatography coupled to electrospray ionization mass spectrometry. Amyloid: Int. J. Exp. Clin. Invest. 1999, 6, 48-53.
28. Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F. et al., The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009, 132, 1175-1189.
29. Gales, L., Saraiva, M. J., Damas, A. M., Structural basis for the protective role of sulfite against transthyretin amyloid formation. Biochim. Biophys. Acta 2007, 1774, 59-64.
30. Shetty, V., Neubert, T. A., Characterization of novel oxidation products of cysteine in an active site motif peptide of PTP1B. J. Am. Soc. Mass Spectrom 2009, 20, 1540-1548.
31. Mustafa, A. K., Gadalla, M. M., Sen, N., Kim, S. et al., H2S signals through protein S-sulfhydration. Sci. Signal 2009, 2, ra72.
32. Predmore, B. L., Lefer, D. J., Gojon, G., Hydrogen sulfide in biochemistry and medicine. Antioxid. Redox. Signal 2012, 17, 119-140.
33. Calza, L., Fernandez, M., Giuliani, A., Aloe, L. et al., Thyroid hormone activates oligodendrocyte precursors and increases a myelin-forming protein and NGF content in the spinal cord during experimental allergic encephalomyelitis. Proc. Natl. Acad. Sci. USA 2002, 99, 3258-3263.
34. Finsen, B., Owens, T., Innate immune responses in central nervous system inflammation. FEBS Lett. 2011, 85, 3806-3812.
35. Fleming, C. E., Nunes, A. F., Sousa, M. M., Transthyretin: more than meets the eye. Prog. Neurobiol. 2009, 89, 266-276.
36. Calzà, L., Fernandez, M., Giuliani, A., D'Intino, G. et al., Thyroid hormone and remyelination in adult central nervous system: a lesson from an inflammatory-demyelinating disease. Brain Res. Rev. 2005, 48, 339-346.